diff --git a/domains/health/CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md b/domains/health/CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md index 63b8ff9d1..1dba11624 100644 --- a/domains/health/CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md +++ b/domains/health/CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md @@ -34,6 +34,12 @@ The broader 2027 rate environment compounds the pressure into a three-pronged sq This is a proxy inertia story. Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], the incumbents who built their MA economics around coding optimization will struggle to shift toward genuine quality competition. The plans that never relied on coding arbitrage (Devoted, Alignment, Kaiser) are better positioned. + +### Additional Evidence (confirm) +*Source: [[2025-03-26-crfb-ma-overpaid-1-2-trillion]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5* + +CRFB quantifies the coding intensity overpayment at $600 billion over 2025-2034, with MA plans achieving 10% net payment increases from coding even after CMS's 5.9% adjustment. Policy options include raising the minimum coding adjustment from 5.9% to 20%, which could reduce deficits by over $1 trillion. This confirms that chart review exclusion addresses a real and quantifiable overpayment mechanism. The persistence of 10% net gains despite 5.9% adjustment suggests current CMS interventions are insufficient, supporting the rationale for more aggressive chart review exclusion. + --- Relevant Notes: diff --git a/domains/health/favorable-selection-in-medicare-advantage-is-structural-not-fraudulent-because-plan-design-mechanisms-legally-discourage-high-utilizers.md b/domains/health/favorable-selection-in-medicare-advantage-is-structural-not-fraudulent-because-plan-design-mechanisms-legally-discourage-high-utilizers.md new file mode 100644 index 000000000..89ce13c7c --- /dev/null +++ b/domains/health/favorable-selection-in-medicare-advantage-is-structural-not-fraudulent-because-plan-design-mechanisms-legally-discourage-high-utilizers.md @@ -0,0 +1,42 @@ +--- +type: claim +domain: health +description: "Prior authorization and narrow networks create $580B in selection effects over a decade through legal mechanisms that attract healthier beneficiaries" +confidence: likely +source: "Committee for a Responsible Federal Budget via MedPAC data, March 2025" +created: 2026-03-11 +secondary_domains: [grand-strategy] +--- + +# Favorable selection in Medicare Advantage is structural not fraudulent because plan design mechanisms legally discourage high utilizers + +Medicare Advantage favorable selection generates **$580 billion** in overpayments from 2025-2034, nearly matching the $600B from coding intensity. But unlike upcoding — which can constitute fraud — favorable selection operates through legal plan design mechanisms: + +**Prior authorization requirements** create friction for care access, discouraging enrollment by beneficiaries who anticipate high utilization. + +**Narrow provider networks** limit access to specialists and facilities, making plans less attractive to those with complex conditions. + +These mechanisms cause healthier beneficiaries to self-select into MA plans. The result: MA plans receive risk-adjusted payments calibrated to beneficiary health status, but the beneficiaries who enroll are systematically healthier than their risk scores predict. This creates an 11% cost advantage versus fee-for-service in 2025 from selection effects alone. + +## Why This Is Structural + +Favorable selection is not a compliance failure — it's rational business strategy. MA plans benefit from attracting healthier members, and plan design tools that accomplish this are legal. There's no fraud to prosecute, no bad actor to sanction. The overpayment is built into the payment model's interaction with plan incentives. + +## Policy Implications + +Because favorable selection is structural rather than fraudulent: +- Compliance enforcement cannot solve it +- Risk adjustment improvements have limited impact (selection happens before risk scoring) +- Only payment model reform or plan design restrictions can address it + +The $580B favorable selection component represents a systematic transfer from taxpayers to MA plans that operates entirely within legal boundaries. This makes it politically harder to address than coding fraud, despite being equally large. + +--- + +Relevant Notes: +- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] +- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]] +- [[four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable]] + +Topics: +- [[domains/health/_map]] diff --git a/domains/health/medicare-advantage-overpayments-total-1-2-trillion-over-2025-2034-driven-equally-by-coding-intensity-and-favorable-selection.md b/domains/health/medicare-advantage-overpayments-total-1-2-trillion-over-2025-2034-driven-equally-by-coding-intensity-and-favorable-selection.md new file mode 100644 index 000000000..338aa0835 --- /dev/null +++ b/domains/health/medicare-advantage-overpayments-total-1-2-trillion-over-2025-2034-driven-equally-by-coding-intensity-and-favorable-selection.md @@ -0,0 +1,45 @@ +--- +type: claim +domain: health +description: "MedPAC data shows MA overpayments split evenly between upcoding ($600B) and risk selection ($580B) creating fiscal sustainability crisis" +confidence: likely +source: "Committee for a Responsible Federal Budget, Medicare Advantage Will Be Overpaid by $1.2 Trillion (2025-2034), March 2025" +created: 2026-03-11 +secondary_domains: [grand-strategy] +depends_on: + - "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk" +--- + +# Medicare Advantage overpayments total $1.2 trillion over 2025-2034 driven equally by coding intensity and favorable selection + +Medicare Advantage will be overpaid by **$1.2 trillion** from 2025-2034 according to MedPAC data analyzed by CRFB. This overpayment splits nearly evenly between two mechanisms: + +**Coding intensity ($600B):** MA plans code diagnoses more aggressively than traditional Medicare, generating a 10% net payment increase even after CMS's 5.9% coding adjustment. This accounts for $260B in Medicare HI Trust Fund impact and $110B in beneficiary premium costs. + +**Favorable selection ($580B):** MA plans attract healthier beneficiaries through plan design (prior authorization, narrow networks) that discourages care-seeking. This structural selection advantage causes 11% higher MA costs versus fee-for-service in 2025 from selection effects alone, accounting for $250B in trust fund impact and $110B in premium costs. + +The symmetry between these drivers is significant: policy debate focuses on upcoding fraud, but favorable selection is almost exactly as large — and it's structural, not illegal. MA plans profit from attracting healthier members through mechanisms that are rational business strategy but create systematic overpayment. + +## Fiscal Impact + +- **Combined trust fund impact:** ~$510 billion over the decade +- **Combined beneficiary premium impact:** ~$220 billion +- MA overpayments are one of the largest single drivers of Medicare spending growth + +## Policy Options + +CBO estimates that reducing MA benchmarks could save **$489 billion**. Raising the minimum coding adjustment from 5.9% to 20% could reduce deficits by **over $1 trillion**. Both reforms would substantially extend Medicare trust fund solvency. + +## Why This Matters + +The $1.2T scale transforms MA payment structure from a pricing error into a Medicare solvency issue. Combined with trust fund insolvency acceleration (now 2040 due to recent legislation), this creates a fiscal collision course where unreformed MA payment mechanics directly threaten Medicare's financial sustainability. + +--- + +Relevant Notes: +- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] +- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]] +- [[four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable]] + +Topics: +- [[domains/health/_map]] diff --git a/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md b/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md index eb54caa1d..f0a2e26a8 100644 --- a/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md +++ b/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md @@ -23,6 +23,12 @@ The Making Care Primary model's termination in June 2025 (after just 12 months, PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes. + +### Additional Evidence (extend) +*Source: [[2025-03-26-crfb-ma-overpaid-1-2-trillion]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5* + +CRFB's analysis of MedPAC data quantifies the fiscal stakes of incomplete risk transfer: MA overpayments total $1.2 trillion over 2025-2034, with $600B from coding intensity and $580B from favorable selection. The coding intensity component persists despite CMS's 5.9% adjustment because MA plans achieve 10% net payment increases through more aggressive diagnosis coding. The favorable selection component — nearly as large — operates through legal plan design mechanisms (prior authorization, narrow networks) that attract healthier beneficiaries. Combined trust fund impact: ~$510 billion over the decade. This represents the fiscal cost of a payment model that touches value metrics (risk adjustment) but doesn't bear full risk (plans profit from selection and coding optimization rather than health improvement). The symmetry between coding and selection drivers suggests that payment boundary problems are structural: even when CMS adjusts for one mechanism (5.9% coding adjustment), plans optimize around the other (favorable selection), keeping total overpayment constant. + --- Relevant Notes: diff --git a/inbox/archive/2025-03-26-crfb-ma-overpaid-1-2-trillion.md b/inbox/archive/2025-03-26-crfb-ma-overpaid-1-2-trillion.md index 9da2d0bd6..5e5813d44 100644 --- a/inbox/archive/2025-03-26-crfb-ma-overpaid-1-2-trillion.md +++ b/inbox/archive/2025-03-26-crfb-ma-overpaid-1-2-trillion.md @@ -7,9 +7,15 @@ date: 2025-03-26 domain: health secondary_domains: [] format: report -status: unprocessed +status: processed priority: high tags: [medicare-advantage, overpayment, fiscal-impact, coding-intensity, favorable-selection, trust-fund] +processed_by: vida +processed_date: 2026-03-11 +claims_extracted: ["medicare-advantage-overpayments-total-1-2-trillion-over-2025-2034-driven-equally-by-coding-intensity-and-favorable-selection.md", "favorable-selection-in-medicare-advantage-is-structural-not-fraudulent-because-plan-design-mechanisms-legally-discourage-high-utilizers.md"] +enrichments_applied: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md", "CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md"] +extraction_model: "anthropic/claude-sonnet-4.5" +extraction_notes: "Extracted two claims: (1) the $1.2T overpayment scale and dual-driver structure, (2) favorable selection as structural vs fraudulent mechanism. Enriched two existing claims with fiscal quantification. The favorable selection insight is the less-discussed half of MA overpayment — it's as large as coding intensity but operates through legal plan design, making it harder to address politically. Connection to proxy inertia: MA plans' current profitability from selection and coding optimization creates rational resistance to payment reform." --- ## Content @@ -50,3 +56,13 @@ tags: [medicare-advantage, overpayment, fiscal-impact, coding-intensity, favorab PRIMARY CONNECTION: [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] WHY ARCHIVED: Quantifies the fiscal stakes of MA reform — connects insurance market structure to Medicare solvency timeline. EXTRACTION HINT: The favorable selection mechanism deserves its own claim — it's the less-discussed half of the overpayment equation. + + +## Key Facts +- MA overpayments: $1.2 trillion over 2025-2034 (MedPAC data via CRFB) +- Coding intensity component: $600B ($260B trust fund, $110B premiums) +- Favorable selection component: $580B ($250B trust fund, $110B premiums) +- MA plans achieve 10% net payment increase from coding after 5.9% CMS adjustment +- Favorable selection causes 11% higher MA costs vs FFS in 2025 +- CBO estimates benchmark reduction could save $489B +- Raising coding adjustment to 20% could reduce deficits by >$1T